1stBiome is a gut-focused platform company engineering beneficial microbes to reduce low-grade inflammation and support metabolic health and longevity. The company combines advanced microbiology, genetic engineering, and deep biological insight to create scalable, affordable oral nutritional solutions with multiple downstream health benefits. Their platform targets key biological drivers of chronic disease and aging by modulating the gut to promote a healthier microbiome, appetite signaling, and reduced inflammation. They pursue collaborations with established consumer health and nutrition brands to bring next-generation probiotic products to market, with a focus on preventive gut and metabolic health.
No recent news for this company.